News + events
News + events

Why Bring the Engineering in Early?
Outgrown your lab? Start with the engineering. Life sciences scale-ups often find their space limits the moment the team grows. Here’s how Inuti helps teams find a lab building that works.

What to Expect From a Site Assessment
A conversation with Dominic Weston, Technical Associate, Inuti Global

Everyone in the Room
Teams are back from summer. Labs fill up again. The new academic year sends a fresh wave of scientists looking for their first space, and Q4 planning puts next year's facility decisions on the table.

The Next Wave of UK Pharma
For most of 2025, the uncertainty around drug pricing and NHS medicine access made it hard to commit to a multi-year facility programme with confidence. That has changed in the last two months.

Why Bring the Engineering in Early?
Outgrown your lab? Start with the engineering. Life sciences scale-ups often find their space limits the moment the team grows. Here’s how Inuti helps teams find a lab building that works.

Everyone in the Room
Teams are back from summer. Labs fill up again. The new academic year sends a fresh wave of scientists looking for their first space, and Q4 planning puts next year's facility decisions on the table.

What to Expect From a Site Assessment
A conversation with Dominic Weston, Technical Associate, Inuti Global

The Next Wave of UK Pharma
For most of 2025, the uncertainty around drug pricing and NHS medicine access made it hard to commit to a multi-year facility programme with confidence. That has changed in the last two months.

Why Bring the Engineering in Early?
Outgrown your lab? Start with the engineering. Life sciences scale-ups often find their space limits the moment the team grows. Here’s how Inuti helps teams find a lab building that works.

Everyone in the Room
Teams are back from summer. Labs fill up again. The new academic year sends a fresh wave of scientists looking for their first space, and Q4 planning puts next year's facility decisions on the table.

What to Expect From a Site Assessment
A conversation with Dominic Weston, Technical Associate, Inuti Global

The Next Wave of UK Pharma
For most of 2025, the uncertainty around drug pricing and NHS medicine access made it hard to commit to a multi-year facility programme with confidence. That has changed in the last two months.
2025 © Inuti
|
Part of the Atria Group
2025 © Inuti
|
Part of the Atria Group
2025 © Inuti
|
Part of the Atria Group